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care resources. Data from 2001 to 2003 were collected from
the National Health Insurance Research Database (NHIRD),
containing health insurance enrollments and claims data
from over 97% of the Taiwanese population. Incident HZ
cases were identiﬁed through HZ diagnosis codes on health
care claims. Overall incidence rates were age-and sex-
adjusted. The cost of outpatient visits and hospitalizations
were obtained. The prescription patterns of antiviral and
neuropathic pain medications were examined. The data will
be presented in the meeting.
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Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN):
Burden of Illness, Healthcare Utilization, and Costs; the
Thai Perspective
P. Pitisuttihum
Faculty of Tropical Medicine, Mahidol University, Bangkok,
Thailand
Background: Herpes Zoster is characterized by vesicular
cutaneous eruption with dermatomal distribution and is
mostly associated with debilitating pain and, later, post-
herpetic neuralgia, especially among patients aged more
than 50 years, despite early treatment with antiviral drugs.
This study aimed to measure the burden of disease, assess
the impact on quality of life, and determine healthcare
resource utilization and costs associated with HZ and PHN
in Thailand.
Methods: This was a prospective cohort study of patients
presenting with Zoster rash in 7 hospitals in Thailand. The
burden of illness and quality of life due to zoster- associated
pain were measured using the Zoster Brief Pain Inventory,
the Initial Zoster Impact Questionnaire, and the Euro-QoL.
Healthcare utilization, costs, and work-time and produc-
tivity lost due to both HZ and PHN, were measured by
simple questionnaire describing visits to physicians or clin-
ics, hospitalizations, use of other health-related services,
prescription medications, over-the-counter medications, as
well as diagnostic tests and procedures performed for the
current episode. Healthcare costs were estimated from
healthcare utilization data. Indirect costs were measured
by simple descriptive questionnaire, to determine time off
work taken by patients or caretakers, and lost income.
The above parameters were followed at each visit, at
days 0, 7, and months 1, 3, and 6.
Results: 180 patients with HZ were enrolled; 138 were
elderly (aged >50 years), 34 were HIV-infected, and 8 were
cancer patients. 160 and 104 patients completed month 3
and month 6, follow up respectively (April 10, 08). About
54% presented with rashes, primarily affected the thoracic
dermatome; 93.8% reported pain. The detailed results for
burden of illness, quality of life, and healthcare costs will
be presented.
doi:10.1016/j.ijid.2008.05.069
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he Changing Epidemiology of Fungal Infection: New
athogens and Problems
. Sathapatayavongs
Faculty of Medicine Ramathibodi Hospital, Mahidol Univer-
ity, Bangkok, Thailand
nvasive fungal infection is increasingly recognized as one of
he major causes of mortality and morbidity in healthcare.
his is due to the increase in susceptible hosts result-
ng from various factors such as intense antineoplastic and
mmunosuppressive agents, breakdown of anatomical barri-
rs, prolonged use of the intravascular catheter, parenteral
utrition, aggressive surgical procedures, broad-spectrum
ntibacterial agents, and HIV infection. Candida spp. and
spergillus spp. are the two most frequently pathogens
solated during the past 2 decades. Although both remain
ommonest pathogens, the changes in species isolated are
bserved. non-albicans Candida is increasing namely C.
labrata, C. krusei, C. tropicalis, C. parapsilosis, and apart
rom A. fumigatus, A. ﬂavus, A. niger, and A. terreus are
ncreasingly isolated. In the era of intensive chemotherapy
nd radiotherapy followed by the hematopoietic stem cell
ransplantation, Zygomycetes, Fusarium spp. Scedosporium
pp. emerge as very difﬁcult-to-treat pathogens. This may
e explained by the pattern of the use of antifungal agents:
uconazole, itraconazole, and amphotericin B. The selec-
ive pressure of these agents in the presence of prolonged
eutropenia and/or severe immunosuppression predispose
atients with these amphotericinB-resistant fungal infec-
ion. In AIDS patients, Cryptococcus neoformans is the most
ommon systemic fungal pathogen worldwide. In addition,
ndemic fungi such as Histoplasma capsulatum in USA and
enicillium marneffei in Thailand are common AIDS-related
ycoses. Another unique mycosis reported from Thailand
s pythiosis, the infection caused by Pythium insidiosum.
he most recognized form with high morbidity and mor-
ality is arteritis, commonly presented with limb gangrene,
neurysm and ultimately aortic rupture. Almost all patients
ave hemoglobinopathy-thallasemic syndrome and expose
o this organisms in the environment such as rice ﬁeld. Treat-
ent of this entity is still problematic since it is not a true
ungus and the response to the available antifungal agents
s unsatisfactory. Considering its habitat, it is likely that
ythiosis is underrecognized in the Southeast Asia region,
ne should be aware of this entity.
oi:10.1016/j.ijid.2008.05.070
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harmacodynamics of Antifungal Drugs: A Strategy to
ptimize Efﬁcacy
. AndesMadison, WI, USA
harmacodynamic studies examine the relationship between
rug pharmacokinetics and outcome. These investigations
